Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, Li Y, Lee EQ, Beroukhim R, Rinne M, McFaline-Figueroa R, Chukwueke U, McCluskey C, Gaffey S, Cherniack AD, Stefanik J, Doherty L, Taubert C, Cifrino M, LaFrankie D, Graillon T, Wen PY, Ligon KL, Al-Mefty O, Huang RY, Muzikansky A, Chiocca EA, Santagata S, Dunn IF, Reardon DA. Bi WL, et al. Among authors: graillon t. Neuro Oncol. 2022 Jan 5;24(1):101-113. doi: 10.1093/neuonc/noab118. Neuro Oncol. 2022. PMID: 34015129 Free PMC article. Clinical Trial.
Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan.
Farina P, Tabouret E, Lehmann P, Barrie M, Petrirena G, Campello C, Boucard C, Graillon T, Girard N, Chinot O. Farina P, et al. Among authors: graillon t. J Neurooncol. 2017 May;132(3):433-437. doi: 10.1007/s11060-017-2385-0. Epub 2017 Mar 6. J Neurooncol. 2017. PMID: 28265824
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
Graillon T, Sanson M, Campello C, Idbaih A, Peyre M, Peyrière H, Basset N, Autran D, Roche C, Kalamarides M, Roche PH, Fuentes S, Tabouret E, Barrie M, Cohen A, Honoré S, Boucekine M, Baumstarck K, Figarella-Branger D, Barlier A, Dufour H, Chinot OL. Graillon T, et al. Clin Cancer Res. 2020 Feb 1;26(3):552-557. doi: 10.1158/1078-0432.CCR-19-2109. Epub 2020 Jan 22. Clin Cancer Res. 2020. PMID: 31969329 Clinical Trial.
Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort.
Le Van T, Graillon T, Jacob J, Vauleon E, Feuvret L, Boch AL, Boetto J, Boone M, Bronnimann C, Caire F, De Barros A, Delaitre M, Di Stefano AL, Dore M, Ducray F, Dufour C, Engelhardt J, Fontaine D, Froelich S, Helleringer M, Huchet A, Joncour A, Jouanneau E, Mallereau CH, Monfilliette A, Le Fur E, Zemmoura I, Chinot O, Sanson M, Kalamarides M, Loiseau H, Peyre M. Le Van T, et al. Among authors: graillon t. J Neurooncol. 2021 May;153(1):55-64. doi: 10.1007/s11060-021-03741-7. Epub 2021 Mar 28. J Neurooncol. 2021. PMID: 33778930
119 results